EP3313441
Ónæmisstilling og meðhöndlun á föstum æxlum með mótefnum sem bindast CD38 sértækt
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.6.2016EP published:
21.2.2024EP application number:
16815351.8
EP translation filed:
22.4.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
23.6.2036Expiry date:
23.6.2026Next due date:
30.6.2026
Title in English:
IMMUNE MODULATION AND TREATMENT OF SOLID TUMORS WITH ANTIBODIES THAT SPECIFICALLY BIND CD38Language of the patent:
English
Timeline
Today
24.6.2016EP application
21.2.2024EP Publication
22.4.2024Translation submitted
15.5.2024Registration published
23.6.2026Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Inventor
Name:
AHMADI, TahamtanAddress:
Spring House, Pennsylvania 19477, US
Name:
CASNEUF, TinekeAddress:
1081 HV Amsterdam, NL
Name:
LOKHORST, Henk M.Address:
1081 HV Amsterdam, NL
Name:
MUTIS, TunaAddress:
1081 HV Amsterdam, NL
Name:
SASSER, AmyAddress:
Doylestown, Pennsylvania 18901, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562184018 PDate:
24.6.2015Country:
US
Number:
201562249546 PDate:
2.11.2015Country:
US
Number:
201562250566 PDate:
4.11.2015Country:
US
Number:
201562263307 PDate:
4.12.2015Country:
US
Number:
201662331489 PDate:
4.5.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/39, A61K 39/395, C07K 16/30, A61P 37/04, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 7.5.2024
Expires: 23.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.6.2025
Expires: 23.6.2026
Payer: Árnason Faktor ehf.